Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - TG THERAPEUTICS, INC. | tgtx_ex322.htm |
| EX-32.1 - EXHIBIT 32.1 - TG THERAPEUTICS, INC. | tgtx_ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - TG THERAPEUTICS, INC. | tgtx_ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - TG THERAPEUTICS, INC. | tgtx_ex311.htm |
| EX-21.1 - EXHIBIT 21.1 - TG THERAPEUTICS, INC. | tgtx_ex211.htm |
| 10-K - 10-K - TG THERAPEUTICS, INC. | tgtx_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting
Firm
We
consent to the incorporation by reference in registration statement
No. 333-181439 on Form S-8 and registration statement Nos.
333-189015 and 333-201339 on Form S-3 of our report dated March 15,
2017 on our audits of the consolidated financial statements of TG
Therapeutics, Inc. and Subsidiaries as of December 31, 2016 and
2015, and for each of the three years in the period ended December
31, 2016, and our report on our audit of internal control over
financial reporting of TG Therapeutics, Inc. and Subsidiaries as of
December 31, 2016, dated March 16, 2017, included in this Annual
Report on Form 10-K of TG Therapeutics, Inc. and Subsidiaries for
the year ended December 31, 2016.
/s/
CohnReznick LLP
New
York, New York
March
15, 2017